Antiviral Activity of Tumour Necrosis Factor. Synergism with Interferons and Induction of Oligo-2′,5′-adenylate Synthetase

References

1. CARSWELL E. A., OLD L. J., KASSEL R. L., GREEN S., FIORE N., WILLIAMSON B. 1975; An endotoxin-induced serum factor that causes necrosis of tumors. Proceedings of the National Academy of Sciences, U.S.A 72:3666–3670
   [Google Scholar]
2. CHIRGWIN J. M., PRZYBYLA A. E., MACDONALD R. J., RUTTER W. J. 1979; Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299
   [Google Scholar]
3. CZARNIECKI C. W., FENNIE C. W., POWERS D. P., ESTELL D. A. 1984; Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons. Journal of Virology 49:490–496
   [Google Scholar]
4. DEFILIPPI P., POUPART P., TAVERNIER J., FIERS W., CONTENT J. 1987; Induction and regulation of mRNA encoding 26-kDa protein in human cell lines treated with recombinant human tumor necrosis factor. Proceedings of the National Academy of Sciences, U.S.A 84:4557–4561
   [Google Scholar]
5. DINARELLO C. A., CANNON J. G., WOLFF S. M., BERNHEIM H. A., BEUTLER B., CERAMI A., FIGARI I. S., PALLADINO M. A. JR, O’CONNOR J. V. 1986; Tumor necrosis factor (cachectin) is an endogeneous pyrogen and induces production of interleukin 1. Journal of Experimental Medicine 163:1433–1450
   [Google Scholar]
6. FALTYNEK C R., MCCANDLESS S., CHEBATH J., BAGLIONI C. 1985; Different mechanisms for activation of gene transcription by interferons β and γ. Virology 144:173–180
   [Google Scholar]
7. FEINBERG A. P., VOGELSTEIN B. 1983; A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Analytical Biochemistry 132:6–13
   [Google Scholar]
8. FRAKER P. J., SPECK J. C. 1978; Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrochloro-3α,6α-diphenylglycoluril. Biochemical and Biophysical Research Communications 80:849–857
   [Google Scholar]
9. FRANSEN L., MÜLLER R., MARMENOUT A., TAVERNIER J., VAN DER HEYDEN J., KAWASHIMA E., CHOLLET A., TIZARD R., VAN HEUWERSWYN H., VAN VLIET A., RUYSSCHAERT M., FIERS W. 1985; Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Research 13:4417–4429
   [Google Scholar]
10. KLEBANOFF S. J., VADAS M. A., HARLAN J. M., SPARKS L. H., GAMBLE J. R., AGOSTI J. M., WALTERSDORPH A. M. 1986; Stimulation of neutrophils by tumor necrosis factor. Journal of Immunology 136:4220–4225
    [Google Scholar]
11. KNIGHT M., CAYLEY P. J., SILVERMAN R. H., WRESCHNER D. H., GILBERT C. S., BROWN R. E., KERR I. M. 1980; Radioimmune, radiobinding and HPLC analysis of 2·5 A and related oligonucleotides from intact cells. Nature, London 288:189–192
    [Google Scholar]
12. KOHASE M., HENRIKSEN-DE STEFANO D., MAY L. T., VILCEK J., SEHGAL P. B. 1986; Induction of β²-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 45:659–666
    [Google Scholar]
13. MANIATIS T., FF.ITSCH E. F., SAMBROOK J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
14. MARMENOUT A., FRANSEN L., TAVERNIER J., VAN DER HEYDEN J., TIZARD R., KAWASHIMA E., SHAW A., JOHNSON M., SEMON D., MÜLLER R., RUYSSCHAERT M., VAN VLIET A., FIERS W. 1985; Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor. European Journal of Biochemistry 152:515–522
    [Google Scholar]
15. MESTAN J., DIGEL W., MITTNACHT S., HILLEN H., BLOHM D., MÖLLER A., JACOBSEN H., KIRCHNER H. 1986; Antiviral effects of recombinant tumour necrosis factor in vitro. Nature, London 323:816–819
    [Google Scholar]
16. NAWROTH P. P., BANK I., HANDLEY D., CASSIMERIS J., CHESS L., STERN D. 1986; Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. Journal of Experimental Medicine 163:1363–1375
    [Google Scholar]
17. OLD L. J. 1985; Tumor necrosis factor (TNF). Science 230:630–632
    [Google Scholar]
18. OLESZAK E., STEWART W. E. 1985; Potentiation of the antiviral and anticellular activities of interferons by mixtures of huIFN-γ and huIFN-α or huIFN-β. Journal of Interferon Research 5:361–371
    [Google Scholar]
19. PENNICA D., NEDWIN G. E., HAYFLICK J. S., SEEBURG P. H., DERYNCK R., PALLADINO M. A., KOHR W. J., AGGARWAL B. B., GOEDDEL D. V. 1984; Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature, London 312:724–729
    [Google Scholar]
20. SHALABY M. R., AGGARWAL B. B., RINDERKNECHT E., SVEDERSKY L. P., FINKLE B. S., PALLADINO M. A. JR 1985; Activation of human polymorphonuclear neutrophil functions by interferon-γ and tumor necrosis factors. Journal of Immunology 135:2069–2073
    [Google Scholar]
21. SHIRAI T., YAMAGUCHI H., ITO H., TODD C. W., WALLACE R. B. 1985; Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor. Nature, London 313:803–806
    [Google Scholar]
22. SILBERSTEIN D. S., DAVID J. R. 1986; Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. Proceedings of the National Academy of Sciences, U.S.A 83:1055–1059
    [Google Scholar]
23. SILVERMAN R. H., WATLING D., BALKWILL F. R., TROWSDALE J., KERR I. M. 1982; The ppp(A2′p)_nA and protein kinase systems in wild-type and interferon-resistant Daudi cells. European Journal of Biochemistry 126:333–341
    [Google Scholar]
24. SUGARMAN B. J., AGGARWAL B. B., HASS P. E., FIGARI I. S., PALLADINO M. A. JR, SHEPARD H. M. 1985; Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 230:943–945
    [Google Scholar]
25. TSUJIMOTO M., YIP Y. K., VILCEK J. 1986; Interferon-γ enhances expression of cellular receptors for tumor necrosis factor. Journal of Immunology 136:2441–2444
    [Google Scholar]
26. VAN DAMME J., DE LEY M., VAN SNICK J., DINARELLO C. A., BILLIAU A. 1987; The role of IFN-α₁ and the 26-kDa protein (interferon-β₂) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor. Journal of Immunology 139:1867–1872
    [Google Scholar]
27. VILCEK J., PALOMBELLA V. J., HENRYKSEN-DESTEFANO D., SWENSON C, FEINMAN R., HIRAI M., TSUJIMOTO M. 1986; Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. Journal of Experimental Medicine 163:632–643
    [Google Scholar]
28. WANG A. M., CREASEY A. A., LADNER M. B., LIN L. S., STRICKLER J., VAN ARSDELL J. N., YAMAMOTO R., MARK D. F. 1985; Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 228:149–228
    [Google Scholar]
29. WONG G. H. W., GOEDDEL D. V. 1986; Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature, London 323:819–822
    [Google Scholar]